0001438133-20-000002.txt : 20200117 0001438133-20-000002.hdr.sgml : 20200117 20200117185735 ACCESSION NUMBER: 0001438133-20-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200116 FILED AS OF DATE: 20200117 DATE AS OF CHANGE: 20200117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HANSEN BRIAN B CENTRAL INDEX KEY: 0001542377 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 20534700 MAIL ADDRESS: STREET 1: 10210 GENETIC CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 4 1 wf-form4_157930543731668.xml FORM 4 X0306 4 2020-01-16 0 0001438133 TANDEM DIABETES CARE INC TNDM 0001542377 HANSEN BRIAN B 11075 ROSELLE ST SAN DIEGO CA 92121 0 1 0 0 EVP & CHIEF COMMERCIAL OFFICER Common Stock 2020-01-16 4 M 0 10000 0 A 12991 D Common Stock 2020-01-16 4 S 0 10000 69.762 D 2991 D Stock Option 2.59 2020-01-16 4 M 0 10000 0 A Common Stock 10000.0 0 D The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $69.76 and $69.77. The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equalmonthly installments thereafter. The expiration date for these options is 10 years from the date of grant. /s/David Berger, Attorney-in-fact for Brian B. Hansen 2020-01-17